|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ABCA1 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
glycitein inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] |
CTD |
PMID:34217736 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Add2 |
adducin 2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ADD2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 4:118,444,594...118,538,505
Ensembl chr 4:118,497,416...118,538,505
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity |
ISO |
glycitein results in increased activity of AHR protein |
CTD |
PMID:17869316 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ALDH1A2 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ANPEP mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
glycitein results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:15757668 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of ATOH8 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
|
|
G |
Atp6v0a2 |
ATPase H+ transporting V0 subunit a2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ATP6V0A2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr12:31,947,220...31,979,875
Ensembl chr12:31,822,733...32,007,069
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of BCKDK mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of BPGM mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Cabp5 |
calcium binding protein 5 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CABP5 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:74,350,811...74,363,830
Ensembl chr 1:74,350,811...74,363,830
|
|
G |
Cacybp |
calcyclin binding protein |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA |
CTD |
PMID:27424125 |
|
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
|
|
G |
Casp8ap2 |
caspase 8 associated protein 2 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 5:47,014,501...47,052,276
Ensembl chr 5:47,014,667...47,052,275
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
glycitein results in decreased expression of CCNA2 |
CTD |
PMID:21161820 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
glycitein results in increased expression of CCND1 mRNA |
CTD |
PMID:19800779 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd200r1 |
CD200 receptor 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CD200R1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr11:55,886,937...55,921,217
Ensembl chr11:55,887,717...55,921,285
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases activity |
ISO |
glycitein results in decreased activity of CDK4 protein |
CTD |
PMID:21161820 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
ESR2 affects the reaction [glycitein results in increased expression of CDKN1A] |
CTD |
PMID:21161820 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cfap251 |
cilia and flagella associated protein 251 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CFAP251 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr12:33,261,622...33,337,028
Ensembl chr12:33,261,476...33,293,932
|
|
G |
Cybrd1 |
cytochrome b reductase 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 3:55,934,874...55,962,132
Ensembl chr 3:55,934,874...55,962,108
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:28964809 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Dennd2d |
DENN domain containing 2D |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT1 mRNA |
CTD |
PMID:28964809 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA |
CTD |
PMID:28964809 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dock3 |
dedicator of cyto-kinesis 3 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of DOCK3 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
|
|
G |
Dpp9 |
dipeptidyl peptidase 9 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 9:1,011,347...1,046,337
Ensembl chr 9:1,011,351...1,046,541
|
|
G |
Edrf1 |
erythroid differentiation regulatory factor 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of EDRF1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:188,441,514...188,478,743
Ensembl chr 1:188,441,634...188,478,701
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of EFHD1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
Epha1 |
Eph receptor A1 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
|
|
G |
Espn |
espin |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ESPN mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions affects binding |
ISO |
glycitein inhibits the reaction [Estradiol binds to ESR1 protein] glycitein binds to ESR1 protein |
CTD |
PMID:14579009 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions affects response to substance |
ISO EXP |
ESR2 affects the reaction [glycitein results in increased expression of CDKN1A] ESR2 affects the susceptibility to glycitein [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of ESR2 mRNA |
CTD |
PMID:21161820 PMID:28964809 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fam171a2 |
family with sequence similarity 171, member A2 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of FAM171A2 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr10:87,393,888...87,404,051
Ensembl chr10:87,394,007...87,404,053
|
|
G |
Fam180a |
family with sequence similarity 180, member A |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM180A mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 4:63,992,867...64,008,047
Ensembl chr 4:63,992,867...64,008,047
|
|
G |
Fam210b |
family with sequence similarity 210, member B |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA |
CTD |
PMID:27424125 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of FGD6 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FHL2 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fmn2 |
formin 2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of FMN2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr13:86,454,256...86,771,437
Ensembl chr13:86,453,926...86,771,411
|
|
G |
Galnt15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr16:7,227,232...7,267,002
Ensembl chr16:7,227,271...7,267,014
|
|
G |
Gng5 |
G protein subunit gamma 5 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of GNG5 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 2:235,394,680...235,403,177
Ensembl chr 1:77,292,043...77,292,513
|
|
G |
Hipk4 |
homeodomain interacting protein kinase 4 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of HIPK4 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:82,810,708...82,821,080
Ensembl chr 1:82,810,708...82,821,077
|
|
G |
Hmcn1 |
hemicentin 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of HMCN1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
EXP |
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:28964809 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Ifrd2 |
interferon-related developmental regulator 2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IFRD2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
|
|
G |
Il6r |
interleukin 6 receptor |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of IL6R mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IRF2BP1 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 1:78,652,736...78,655,437
Ensembl chr 1:78,652,412...78,655,530
|
|
G |
Isg20l2 |
interferon stimulated exonuclease gene 20-like 2 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ISG20L2 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 2:173,396,780...173,407,102
Ensembl chr 2:173,396,780...173,406,614
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases activity |
ISO |
glycitein results in increased activity of JUN protein |
CTD |
PMID:17088408 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcng2 |
potassium voltage-gated channel modifier subfamily G member 2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of KCNG2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723
|
|
G |
Kdm5a |
lysine demethylase 5A |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 4:153,565,909...153,643,912
Ensembl chr 4:153,565,846...153,642,422
|
|
G |
Kitlg |
KIT ligand |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
|
|
G |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LDLRAP1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 5:146,955,607...146,978,601
Ensembl chr 5:146,955,607...146,978,601
|
|
G |
Lmod1 |
leiomodin 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LMOD1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr13:46,754,048...46,796,186
Ensembl chr13:46,754,033...46,794,900
|
|
G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of LRG1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
|
|
G |
Lsr |
lipolysis stimulated lipoprotein receptor |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LSR mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] glycitein results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:17088408 PMID:20188714 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] glycitein results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:17088408 PMID:20188714 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
decreases expression |
ISO |
glycitein results in decreased expression of MMP3 mRNA; glycitein results in decreased expression of MMP3 protein |
CTD |
PMID:20188714 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] glycitein results in decreased expression of MMP9 mRNA; glycitein results in decreased expression of MMP9 protein |
CTD |
PMID:20188714 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mrpl33 |
mitochondrial ribosomal protein L33 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of MRPL33 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 6:24,825,800...24,833,994
Ensembl chr 6:24,825,827...24,833,834
|
|
G |
Mtmr11 |
myotubularin related protein 11 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of MTMR11 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 2:183,721,983...183,732,148
Ensembl chr 2:183,723,530...183,732,148
|
|
G |
Myof |
myoferlin |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases activity |
ISO |
glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; glycitein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] glycitein results in decreased activity of NOS2 protein |
CTD |
PMID:11308324 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
multiple interactions |
EXP |
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 mRNA; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 protein; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased methylation of NR5A1 promoter; decitabine inhibits the reaction [[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 mRNA] |
CTD |
PMID:28964809 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
glycitein results in increased expression of NRIP1 mRNA |
CTD |
PMID:15757668 |
|
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Olfml3 |
olfactomedin-like 3 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of OLFML3 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
glycitein results in decreased expression of PCNA |
CTD |
PMID:21161820 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PDLIM2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
|
|
G |
Pnn |
pinin, desmosome associated protein |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PNN mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
|
|
G |
Pou4f2 |
POU class 4 homeobox 2 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of POU4F2 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr19:29,486,686...29,490,327
Ensembl chr19:29,486,686...29,490,327
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA |
CTD |
PMID:27424125 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prpf40a |
pre-mRNA processing factor 40 homolog A |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of PRPF40A mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 3:37,625,585...37,689,859
Ensembl chr 3:37,627,690...37,690,886
|
|
G |
Pspc1 |
paraspeckle component 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of PSPC1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr15:30,828,617...30,911,315
Ensembl chr15:30,828,626...30,911,202
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of PTH1R mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 8:110,693,910...110,725,458
Ensembl chr 8:110,697,485...110,719,729
|
|
G |
Rassf5 |
Ras association domain family member 5 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of RASSF5 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr13:42,637,513...42,703,024
Ensembl chr13:42,637,549...42,703,024
|
|
G |
Rgs22 |
regulator of G-protein signaling 22 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of RGS22 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 7:67,188,531...67,308,805
Ensembl chr 7:67,188,519...67,308,875
|
|
G |
Rps6ka3 |
ribosomal protein S6 kinase A3 |
increases expression |
ISO |
glycitein results in increased expression of RPS6KA3 mRNA |
CTD |
PMID:15757668 |
|
NCBI chr X:35,517,306...35,623,296
Ensembl chr X:35,517,306...35,623,207
|
|
G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr17:13,781,050...13,794,408
Ensembl chr17:13,781,050...13,794,505
|
|
G |
Selplg |
selectin P ligand |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SELPLG mRNA |
CTD |
PMID:27424125 |
|
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
|
|
G |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of SGPP1 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 6:94,425,339...94,446,534
Ensembl chr 6:94,425,339...94,446,534
|
|
G |
Siglec10 |
sialic acid binding Ig-like lectin 10 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SIGLEC10 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:93,817,301...93,826,376
Ensembl chr 1:93,817,335...93,825,931
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
decreases expression |
ISO |
glycitein results in decreased expression of SLC12A2 mRNA |
CTD |
PMID:15757668 |
|
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
increases uptake |
ISO |
SLC22A8 protein results in increased uptake of glycitein analog |
CTD |
PMID:21244849 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Snx30 |
sorting nexin family member 30 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SNX30 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 5:74,683,902...74,813,013
Ensembl chr 5:74,684,015...74,792,631
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions increases activity |
ISO |
glycitein promotes the reaction [SP1 protein binds to VDR promoter]; U 0126 inhibits the reaction [glycitein results in increased activity of SP1 protein] |
CTD |
PMID:17088408 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Ssc5d |
scavenger receptor cysteine rich family member with 5 domains |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SSC5D mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 1:68,891,942...68,910,462
Ensembl chr 1:68,891,949...68,909,743
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR mRNA; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR protein |
CTD |
PMID:28964809 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stc1 |
stanniocalcin 1 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of STC1 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Styxl1 |
serine/threonine/tyrosine interacting-like 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr12:20,907,410...20,940,232
Ensembl chr12:20,907,435...20,939,752
|
|
G |
Sumo1 |
small ubiquitin-like modifier 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of SUMO1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:61,077,435...61,108,761
|
|
G |
Tacr3 |
tachykinin receptor 3 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of TACR3 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 2:223,266,536...223,363,791
Ensembl chr 2:223,266,536...223,363,791
|
|
G |
Tc2n |
tandem C2 domains, nuclear |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of TC2N mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 6:120,761,112...120,856,835
Ensembl chr 6:120,761,119...120,849,326
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of TNFAIP6 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
glycitein results in increased expression of TP53 protein |
CTD |
PMID:19800779 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
decreases expression multiple interactions |
ISO |
glycitein results in decreased expression of TP53I11 mRNA [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of TP53I11 mRNA |
CTD |
PMID:15757668 PMID:27424125 |
|
NCBI chr 3:79,144,824...79,160,056
Ensembl chr 3:79,144,895...79,160,050
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
ISO |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of UCHL1 mRNA |
CTD |
PMID:16963248 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Vcpip1 |
valosin containing protein interacting protein 1 |
multiple interactions |
ISO |
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of VCPIP1 mRNA |
CTD |
PMID:27424125 |
|
NCBI chr 5:9,534,247...9,560,889
Ensembl chr 5:9,534,129...9,562,040
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions increases expression |
ISO |
fulvestrant inhibits the reaction [glycitein results in increased expression of VDR protein]; glycitein promotes the reaction [SP1 protein binds to VDR promoter]; U 0126 inhibits the reaction [glycitein results in increased expression of VDR protein] glycitein results in increased expression of VDR mRNA; glycitein results in increased expression of VDR protein |
CTD |
PMID:17088408 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|